Cargando…
A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two leading causes of severe respiratory infections in children, the elderly, and immunocompromised patients. The fusion (F) protein is the major target of neutralizing antibodies. Recent developments in stabilizing the pre-fusio...
Autores principales: | Huang, Jiachen, Miller, Rose J., Mousa, Jarrod J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393700/ https://www.ncbi.nlm.nih.gov/pubmed/36003370 http://dx.doi.org/10.3389/fimmu.2022.941865 |
Ejemplares similares
-
Antibody Epitopes of Pneumovirus Fusion Proteins
por: Huang, Jiachen, et al.
Publicado: (2019) -
Antibody recognition of the Pneumovirus fusion protein trimer interface
por: Huang, Jiachen, et al.
Publicado: (2020) -
A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV
por: Wen, Xiaolin, et al.
Publicado: (2016) -
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
por: Mousa, Jarrod J., et al.
Publicado: (2018) -
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
por: Soto, Jorge A., et al.
Publicado: (2018)